Search Results 1661-1670 of 20757 for Informed consent

1. Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer - Mayo Clinic

   ... inform her treating physician immediately. Ability to understand and the willingness to sign a written informed consent document. LVEF > 50% calculated by ...

2. A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast Ca - Mayo Clinic

   Able and willing to provide written informed consent; Willingness to return ... Willing to sign consent onto the Mayo Clinic Radiotherapy Patient ...

3. A Study to Compare Docetaxel/Prednisone to Docetaxel/Prednisone Combined with OGX-011 in Men with Prostate Cancer - Mayo Clinic

   Written informed consent must be obtained prior to any protocol-specific procedures being performed. Exclusion Criteria. Received any other cytotoxic ...

4. A Global Study To Assess The Drug Dynamics, Efficacy, And Safety Of GZ/SAR402671 In Parkinson's Disease Patients Carrying A Glucocerebrosidase (GBA) Gene Mutation - Mayo Clinic

   Age ≥18 years to 80 years inclusive at the time of informed consent signing. Has symptoms of PD ≥2 years. Hoehn and Yahr (H and Y) stage of 2 or lower at ...

5. A Study of AFP464 for Treating Patients with Solid Tumors that are Metastatic or Resistant to Treatment, and Cannot Be Removed By Surgery - Mayo Clinic

   Ability to provide informed consent; Willing to return to Mayo Clinic for ... inform her treating physician immediately. History of allergic reactions ...

6. A Study to Collect Tissue Samples from Patients with Myeloproliferative Neoplasms, to Perform a Variety of Biomarker Studies - Mayo Clinic

   Signed an informed consent to participate in a Myeloproliferative Disorders Research Consortium (MPD-RC) treatment study to which this protocol is a companion ...

7. Financial Difficulty in Patients With Blood Cancer - Mayo Clinic

   ... informed consent discussion in Spanish. Inclusion Criteria - Physician: - The physician currently treats patients with chronic lymphocytic leukemia (CLL) ...

8. A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension - Mayo Clinic

   * Participants must be ≥ 18 to ≤ 75 years at the time of signing the informed consent form (ICF). * Participants must have a diagnosis of World Health ...

9. A 4-Week Study Of The Safety, Efficacy, And Pharmacokinetics Of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] In Subjects With Parkinson's Disease And Excessive Sleepiness - Mayo Clinic

   ... informed consent. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date information ...

10. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Capable of giving signed informed consent,. Participants who are overtly healthy as determined by medical evaluation by the investigator or a medically ...